Memory Disorders Clinical Trial
Official title:
COGNITIVE - Comparison of Cognitive Function After Sevoflurane or Propofol Anesthesia for Open-heart Operations
The aim of the study is to prove whether general anesthesia with inhaled sevoflurane reduces the frequency of neurological and cognitive impairment after open-heart operations with use of cardiopulmonary by-pass (CPB) in comparison with intravenous anesthesia with propofol.
Patients assigned to the "sevoflurane" group will be anesthetized with inhaled sevoflurane
(induction and conduction of general anesthesia) and empirically administered fentanyl und
pancuronium. During the CPB, sevoflurane will be delivered via the oxygenator of the
CPB-machine.
Patients assigned to the "propofol" group will be anesthetized with continuous propofol
infusion and empirically administered fentanyl and pancuronium.
The level of anesthesia will be monitored with BIS (bi-spectral index) - desirable level of
40 - 60.
Following preoperative data will be recorded: age, years of school education, NYHA-class,
LVEF by TTE, comorbidities, glucosylated hemoglobin in patients with diabetes, non-invasive
arterial blood pressure the day before the operation, smoked cigarettes, alcohol abuse.
Recorded data from operation: type of surgery, CBP duration, aortic clamp duration, duration
of arterial hypotension (MAP < 60 mmHg) on CPB or SAP < 90 after CPB, the lowest perfusion
gradient (MAP-CVP), the lowest pO2 in arterial blood and lowest blood oxygen saturation,
lowest and average brain blood saturation (measured by INVOS), steroid dosis, aprotinin
dosis, mannitol dosis on CPB, epiaortic echocardiography for aortic clamping, TEE before
weaning from CPB with evaluation of deaeration of the left ventricle, highest serum glucose
level, highest oesophageal temperature.
Data collected after operation: time to tracheal extubation, doses of catecholamines,
consciousness disorders, CRP, S-100b protein, glucose level, core temperature, ICU stay,
stay at the surgery department, hospital stay.
The patients will undergo a psychological examination four times: before the operation,
before discharge from hospital (usually 4-6 days after the operation), 3 and 12 months after
the operation. The psychological test for evaluating the cognitive modalities will include:
1. verbal learning - the Rey's AVLT test
2. direct verbal memory - number repeating attempt from the WAIS-R/PL test
3. direct nonverbal memory - Memory Test of Geometric Figures by Benton
4. operating memory test - TMT test
5. the cognitive interference test - a modified Stroop test
6. verbal fluence - according to the Boston Test of Aphasia
7. concentration and work effectiveness - by the Number Symbol test by Wechsler.
8. mood - Beck's depression scale
9. NEECHAM Delirium Scale - during the first 24-36 hours after surgery
10. the Gough's Adjective Test will be performed with in-house relatives of the patient for
evaluation the eventual emotional and eventual personality changes
Neurological examination will be performed before and 6 days after surgery.
;
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03894254 -
Predictive Factors of Autonomy Loss in Real-life Cohort
|
N/A | |
Not yet recruiting |
NCT03507985 -
Attention and Memory Disorders Related to Acute Morphine
|
||
Terminated |
NCT02521558 -
Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease
|
N/A | |
Completed |
NCT00355498 -
Amyloid Plaque and Tangle Imaging in Aging and Dementia
|
||
Completed |
NCT00010920 -
Preventing Cognitive Decline With Alternative Therapies
|
Phase 3 | |
Not yet recruiting |
NCT04079075 -
Multiple Interventions to Prevent Cognitive Decline
|
N/A | |
Completed |
NCT02185222 -
Effect of Vitamin D on Cognitive Decline of Patients With Memory Complaint
|
Phase 3 | |
Completed |
NCT00289471 -
Identifying Patients With Dementia in Primary Care
|
N/A | |
Terminated |
NCT00548327 -
The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype
|
Phase 2 | |
Completed |
NCT00403507 -
Exercise Treatment of Mild-Stage Probable Alzheimer's Disease
|
Phase 2 | |
Completed |
NCT00387062 -
Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment
|
Phase 1 | |
Completed |
NCT04587583 -
WeCareAdvisor: A Web-Based Tool to Improve Quality of Life for Military Veterans With Dementia and Their Caregivers
|
Phase 1/Phase 2 | |
Completed |
NCT02843529 -
Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI)
|
N/A | |
Active, not recruiting |
NCT03205709 -
Cognitive Training and Neuroplasticity in Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT05509075 -
Nutraceuticals and Functional Foods
|
||
Recruiting |
NCT05065450 -
Amygdala Memory Enhancement
|
N/A | |
Recruiting |
NCT05929144 -
Optimization of MRI Sequences Used in the Study of Neurodegenerative Diseases
|
N/A | |
Active, not recruiting |
NCT03661034 -
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
|
N/A | |
Completed |
NCT02333942 -
Dementia Signal Development Study of Nautilus NeuroWave TM for the Detection of Dementia
|
||
Completed |
NCT02236416 -
Physical Exercise for Prevention of Dementia
|
N/A |